Sbcef S 250mg/125mg Injection
Marketer
Invictus Lifesciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Sbcef S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg Injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and halting infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; the full course should be completed regardless of symptom improvement. Premature cessation can compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, breathing difficulties). Inform your doctor of all other medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration promote recovery. Your physician may order tests to monitor the medication's impact.
Uses of Sbcef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sbcef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Sbcef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sbcef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Sbcef S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam 250mg/125mg Injection (Sbcef S) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, by inhibiting beta-lactamases, counters bacterial resistance mechanisms, thus augmenting Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Sbcef S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Sbcef S 250mg/125mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human clinical trials remains scarce.
Breast feedingCAUTION
Administration of Sbcef S 250mg/125mg Injection requires careful consideration in lactating women. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the patient's system.
DrivingUNSAFE
The administration of Sbcef S 250mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sbcef S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 250mg/125mg Sbcef S Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for the 250mg/125mg Sbcef S Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Sbcef S 250mg/125mg Injection :
Should you forget a scheduled dose of Sbcef S 250mg/125mg Injection, seek medical advice.
Facts to Know About Sbcef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently